Azathioprine - News Articles

Study: Amitiza for IBS-C had 37% response rate - Related Stories - Digestive Health SmartBrief
May 28, 2008
SmartBrief, DC -
A nine-month follow-on study found that one-year treatment with lubiprostone at 8 mcg twice daily had a 37% response rate in patients with irritable bowel syndrome with constipation. MedPage Today (free registration) (05/20) ...
Scleroderma Lung Disease - Health - redOrbit
Jun 3, 2008
RedOrbit, TX -
By Strange, Charlie Seibold, James R If Lewis Carroll (quoted in the title) were alive today, he may well have considered a career in scleroderma research. Systemic sclerosis (SSc; scleroderma) remains without a clearly defined pathogenesis and without an effective overarching approach to therapy. Despite ...
Prognostic Significance of Bronchoalveolar Lavage Cellular Analysis in Scleroderma Lung Disease/From the Authors - Health - redOrbit
Jun 3, 2008
RedOrbit, TX -
To the Editor: Dr. Strange and colleagues concluded in their subgroup analysis of data from the Scleroderma Lung Study that abnormal bronchoalveolar lavage (BAL) cellularity was associated with more advanced interstitial lung disease (ILD), but was of no benefit in predicting disease ...
FDA Announces Soldyn Recall Due to Azasan Product Mix-Up
May 20, 2008
Newsinferno.com, NY -
The US Food and Drug Administration (FDA) just announced today that Medicis issued a voluntary recall of Solodyn®—generically known as minocycline HCL, USP—due to a product mix-up with another medication. The Solodyn® drugs involved in the recall are the 90 ...
Some lots of antibiotic Solodyn recalled - UPI.com
May 19, 2008
United Press International -
WASHINGTON, May 19 (UPI) -- The US Food and Drug Administration announced the voluntarily recall of some lots of the antibiotic Solodyn due to a safety risk . The FDA said the Medicis Pharmaceutical Corp. voluntarily recalled Solodyn (minocycline) extended release tablets in lot numbers ...
Solodyn (minocycline HCL) Extended Release Tablets 90 mg
May 19, 2008
Food Consumer, IL -
By FDA [Posted 05/19/2008] Medicis and FDA notified healthcare professionals of the recall of lot numbers B080037 (Exp: 12/09) and B080038 (Exp: 12/09) of ...
The Associated Press: FDA orders Texas plant to shut down, recall smoked seafood
May 16, 2008
The Associated Press -
WASHINGTON (AP) — Federal health authorities are directing a Pasadena, Texas, company to shut down and recall all its dried smoked catfish steaks and other smoked seafood produced since June 2007 because it failed to develop safety standards, leading to a risk of bacteria ...
Interstitial Lung Disease in Systemic Sclerosis - Health - redOrbit
Jun 5, 2008
RedOrbit, TX -
Treatment was defined as corti-costeroid (prednisolone >/= 1mg/d) and/or immunosuppressant (cyclo-phosphamide, azathioprine, mycophenolate) therapy. PFTs (% predicted), echocardiography, and HRCT were performed as previously reported (10, 11). Pulmonary hypertension was ...
Prescribing Reference: Drug News - Medicis recalls Solodyn
May 20, 2008
Prescribing Reference, New York -
two lots of Solodyn (minocycline HCl extended-release tablets) 90mg because one of the bottles contained Azasan (azathioprine tablets, from Salix) 75mg. ...
Increased Incidence Of Melanoma Found In Rheumatoid Arthritis Patients Treated With Methotrexate
Jun 3, 2008
Science Daily (press release) -
ScienceDaily (Jun. 3, 2008) — A chronic, inflammatory disease of unknown origin, rheumatoid arthritis (RA) affects about 1 percent of adults worldwide. Marked by joint destruction, RA often leads to disability and diminished quality of life. It can also lead to ...
Certain Arthritis Drugs Causing Cancer In Children | Dogs and Human Health Information
Jun 4, 2008
Dog Flu Diet and Diseases, Canada -
June 4 2008 - Tumor necrosis factor blockers is the name of a class of drugs that is being investigated by the FDA due to an apparent link to increased risk of cancer in children. According to the agency, more than 30 reports of lymphoma, leukemia, and other ...
FDA Probes Arthritis Drug Link To Cancer
Jun 4, 2008
Consumer Affairs -
The US Food and Drug Administration has announced an investigation into a class of drugs used to treat arthritis, over concerns they might be linked to the development of cancer. The agency said it has received 30 reports in the last ten years that ...
RTTNews - Breaking News, financial breaking News, Positive EPS Surprises, Stock research ....
Jun 4, 2008
RTT News, NY -
(RTTNews) - Wednesday, Amgen (AMGN: News, Chart, Quote ) and Wyeth Pharmaceuticals announced extending their support to US Food and Drug Administration or FDA's investigation into the possible link between tumor necrosis factor or TNF blockers and cancer. This announcement by ...
abc7chicago.com: Arthritis drugs may be linked to cancers 6/04/08
Jun 4, 2008
ABC7Chicago.com,  USA -
US health officials are investigating whether drugs used to treat rheumatoid arthritis and Crohn's disease are linked to cases of lymphoma and other cancers in children and young adults. The drugs are members of a family called TNF ...
FDA Investigating Remicade, Enbrel, Humira and Cimzia Link to Cancers
Jun 4, 2008
Lawyers and Settlements -
Rockville, MD: The US Food and Drug Administration (FDA) on Wednesday issued an Early Communication release stating that it is investigating a possible association between tumor necrosis factor (TNF) blockers and the development of cancers in children and young adults. The TNF ...
Analysts have high hopes for Abbott Laboratories
Jun 4, 2008
Medill Reports, IL -
by Haley Westbrook Despite whispers of a recession and Wall Street disappointments, one thing is for sure: Analysts have high expectations that reach well beyond this year for global healthcare giant Abbott Laboratories. According to recent research reports from analysts covering ...
FDA Checking for Cancer-TNF Drug Link
Jun 4, 2008
WebMD -
By Daniel J. DeNoon June 4, 2008 -- The FDA is investigating whether cancers in about 30 children and young adults are linked to the use of Remicade, Enbrel, Humira, or Cimzia to treat childhood arthritis , Crohn's, or other diseases. ...
PharmaTimes | Industry News | World News | FDA explores lymphoma link in young treated with TNF blockers
Jun 5, 2008
Pharma Times (subscription), UK -
Regulators in the USA have given notice that they are conducting a safety review into the possible link between the use of tumour necrosis factor blockers and the development of lymphomas and other cancers in children and young adults. The US Food and Drug ...
FDA Investigating Arthritis Drugs And Cancer Risk In Children
Jun 5, 2008
Medical News Today, UK -
The US Food and Drug Administration (FDA) is investigating a possible link between tumor necrosis factor (TNF) blockers, a class of drugs for treating arthritis and other conditions, and cancer risk in children. In an early communication issued yesterday, 4th June, ...
FDA checks arthritis meds for child-cancer link - FiercePharma
Jun 5, 2008
FiercePharma, DC -
By Tracy Staton In a development sure to spawn headlines across the country, the FDA is looking into a possible link between autoimmune drugs such as Remicade and Humira--known as TNF blockers for their action against tumor necrosis factor--and childhood cancers. The meds are already ...

Pages:   1   2   Next

These articles are related to: Azathioprine Claim, Azathioprine Lawsuit, Azathioprine Law Suit, Azathioprine Law Firm, Azathioprine Lawyer, Azathioprine Attorney, Azathioprine Side Effects Symptoms, Azathioprine Trial, Azathioprine Verdict, Azathioprine News, Azathioprine Information, Azathioprine Recall Lawyers, Azathioprine Warning, Azathioprine Class Action, Azathioprine Prescription Drug, Azathioprine Medication, Azathioprine Drugs, Azathioprine Sodium

AddThis Social Bookmark Button

 

Need An Azathioprine Attorney?

First Name Last Name Email Address State
Has Your Health Been Negatively Affected?

Please Describe the Injury
Click to Ask a Question

Your Friend's Email Address

Your Email Address

Type a Message (optional)


 

Need An Azathioprine Lawyer?

First Name Last Name Email Address State
Has Your Health Been Negatively Affected?

Please Describe the Injury
Click to Ask a Question

 

Close (x)

Looking for an Attorney?


Please type your question:

Close (x)

logo Find Legal Help for Your Azathioprine Case - Submit Your Information Below

Do you need legal assistance with your Azathioprine case?
LegalView may be able to help.


Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *
Last name *
Email Address *
Phone Number *
()  -

State *
Legal Issue * FDA Drug Database: Azathioprine Change
Was There an Injury?
Please Describe The Injury

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website [more...]

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.

This form is secure and encrypted. More information about secure forms and your privacy here.